Aerocrine gets expanded US reimbursement coverage; clears more Asian reg hurdles
This article was originally published in Clinica
Executive Summary
Inflammatory airway disease specialist Aerocrine has gained expanded reimbursement coverage in the US for its Niox Mino device for managing asthma, and won marketing clearance for two new Asian markets.